			Home About us Contact

Repeat Injections (repeat + injection)

Distribution by Scientific Domains

Medical Sciences	75%

Selected Abstracts

Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion

ACTA OPHTHALMOLOGICA, Issue 3 2009
Lili Wang
Abstract. Purpose:, To investigate the effectiveness of repeated injections of intravitreal triamcinolone acetonide (IVTA) in the treatment of macular oedema caused by central retinal vein occlusion (CRVO). Methods:, Seventeen pseudophakic or aphakic eyes of 17 patients (10 male, seven female) with macular oedema caused by CRVO received a repeat injection of 4 mg IVTA, 16 weeks after the first injection of the same dose. The examination included measurements of best-corrected visual acuity (BCVA) for distance and central foveal thickness (CFT) by optical coherence tomography (OCT), preoperatively and 1, 2, 3 and 4 months postoperatively. The values were compared by paired- t test. Side-effects were monitored. Results:, BCVA and CFT were not significantly different before initial and repeat injections. Transient improvements of BCVA and CFT were achieved after both injections. At the end of follow-up, BCVA and CFT were significantly different compared to pre-injection values in the same group (P = 0.032, 0.049 in the initial-injection group and P = 0.001, 0.008 in the repeat-injection group, respectively). However, compared to the initial injection, BCVA measurements were significantly worse at each time-point (P = 0.043, 0.011, 0.010 and 0.012, respectively) after the repeat injection, as were CFT at 1, 2 and 3 months post-injection (P = 0.040, 0.015 and 0.025, respectively). The achieved maximum mean intraocular pressures were 20.00 [standard deviation (SD) 2.06] mmHg and 18.56 (SD 3.65) mmHg after the first and repeat injections, respectively. These values were not significantly different (P = 0.467). No other significant adverse events were noted during the study. Conclusion:, A repeat injection of 4 mg IVTA may not be as effective as an initial injection for the treatment of macular oedema caused by CRVO. [source]

Bioremediation of TCE in a fractured limestone aquifer using a novel horizontal passive biobarrier

REMEDIATION, Issue 2 2010
Charlotte E. Riis
This article discusses a project demonstrating the successful use of a novel horizontal biobarrier approach to protect a fractured limestone aquifer from continuing contamination while passive bioremediation of the overlying clay till source area is in progress. The emplacement of the biobarrier has significantly reduced the concentrations of chlorinated ethenes and dechlorination activity in the limestone aquifer, promoting complete reductive dechlorination of the trichloroethene plume. The biobarrier strategy has thus met the challenge of protecting the limestone from the overlying overburden. Direct GeoProbe injections performed in the source area, which consist of a clay till overburden, have also reduced the contaminant concentrations in the clay till due to enhanced dechlorination activity; however, repeat injections may be required to address the areas of the till in which the injectate has not yet been distributed. The time frame for remediating the source area in the till is expected to be on the order of a decade. © 2010 Wiley Periodicals, Inc. [source]

Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem

BJU INTERNATIONAL, Issue 9 2009
AbdolMohammad Kajbafzadeh
OBJECTIVE To report our experience of treating bladder and bowel dysfunction in children with myelomeningocele, with simultaneous laparoscopic antegrade continence enema (LACE) and repeated intravesical injection of botulinum toxin-type A (BTX-A). PATIENTS AND METHODS Six girls and 14 boys (mean age, 8.7 years) with myelomeningocele were included in this study. All patients had received one or two intravesical injection(s) of BTX-A, but had persistent fecal incontinence or constipation despite improved urinary symptoms. We performed a two-port laparoscopic appendicostomy, immediately after repeated intravesical injection of BTX-A, through a V-shaped skin flap at McBurney's point. The stoma was finally covered by a quadrilateral skin flap, using the ,VQ' technique. The degree of urinary incontinence and bowel dysfunction were determined in each patient, and conventional urodynamic studies were performed 4 months after each injection. RESULTS All patients were followed-up for a mean (range) of 19.1 (14,33) months. Urinary continence improved significantly after the first injection, and remained constant after repeat injections. The maximum detrusor pressure, bladder compliance and capacity improved significantly (P < 0.001) compared with baseline. Interestingly, the simultaneous intravesical BTX-A injection/LACE procedure significantly improved all urodynamic variables compared with the values obtained after the last BTX-A injection alone. The laparoscopic procedure was well tolerated, and 19 (95%) children were nappy-free at the final follow-up. Only two patients had stoma stenosis, and one patient had minor stoma leakage. CONCLUSION Concomitant repeat intravesical injection of BTX-A and LACE can effectively manage bladder and bowel dysfunction in children with myelomeningocele. The procedure may further contribute to improve bladder urodynamic function, as effective evacuation of the bowel provides more room for bladder distension. [source]